autologous UCD19 CAR T cells
Term · Oncology and biomedicine · MLC-T-ONC-011810
A preparation of autologous peripheral blood lymphocytes (PBLs) that have been transduced with a lentiviral vector to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon transfusion, the autologous UCD19 CAR-T cells recognize and bind to CD19-expressing tumor cells, thereby selectively lysing CD19-expressing tumor cells. CD19, a B-cell-specific cell surface antigen is overexpressed in B-cell lineage malignancies.
| Identifier | MLC-T-ONC-011810 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous UCD19-CAR T lymphocytes |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011810",
"term": "autologous UCD19 CAR T cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous peripheral blood lymphocytes (PBLs) that have been transduced with a lentiviral vector to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon transfusion, the autologous UCD19 CAR-T cells recognize and bind to CD19-expressing tumor cells, thereby selectively lysing CD19-expressing tumor cells. CD19, a B-cell-specific cell surface antigen is overexpressed in B-cell lineage malignancies.",
"synonyms": [
"autologous UCD19-CAR T lymphocytes"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-ucd19-car-t-cells/"
}
Record 3,148 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.